X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AANJANEYA LIFECARE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ACTAVIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ACTAVIS
Dec-14
DR. DATSONS LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs12618,501-   
Low Rs3111,285-   
Sales per share (Unadj.) Rs133.03,331.6-  
Earnings per share (Unadj.) Rs0.2-415.7-  
Cash flow per share (Unadj.) Rs6.6305.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.87,226.1-  
Shares outstanding (eoy) m31.66265.90-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.5 13.2%   
Avg P/E ratio x516.1-35.8 -1,440.8%  
P/CF ratio (eoy) x11.848.7 24.3%  
Price / Book Value ratio x0.62.1 29.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4773,960,121 0.1%   
No. of employees `000NA21.6 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM41,012.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-5,117.9-  
INCOME DATA
Net Sales Rs m4,211885,865 0.5%  
Other income Rs m79-2,211 -3.6%   
Total revenues Rs m4,289883,654 0.5%   
Gross profit Rs m569113,802 0.5%  
Depreciation Rs m204191,822 0.1%   
Interest Rs m43027,942 1.5%   
Profit before tax Rs m13-108,173 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-7,935 0.0%   
Tax Rs m6-5,561 -0.1%   
Profit after tax Rs m5-110,547 -0.0%  
Gross profit margin %13.512.8 105.1%  
Effective tax rate %48.05.1 934.3%   
Net profit margin %0.1-12.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m6,852466,737 1.5%   
Current liabilities Rs m6,711340,389 2.0%   
Net working cap to sales %3.314.3 23.5%  
Current ratio x1.01.4 74.5%  
Inventory Days Days16158 277.2%  
Debtors Days Days31866 480.5%  
Net fixed assets Rs m3,673108,173 3.4%   
Share capital Rs m3170-   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0781,921,408 0.2%   
Long term debt Rs m1,6711,006,856 0.2%   
Total assets Rs m12,6333,521,309 0.4%  
Interest coverage x1.0-2.9 -35.9%   
Debt to equity ratio x0.40.5 78.2%  
Sales to assets ratio x0.30.3 132.5%   
Return on assets %3.4-2.3 -146.8%  
Return on equity %0.1-5.8 -2.0%  
Return on capital %7.7-3.0 -254.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345152,120 0.9%  
From Investments Rs m-2,256-364,234 0.6%  
From Financial Activity Rs m-1,200204,647 -0.6%  
Net Cashflow Rs m-2,111-7,467 28.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare DR. DATSONS LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: CADILA HEALTHCARE  WYETH LTD  STERLING BIOTECH  ALEMBIC LTD  MERCK LTD  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views On News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS